Comparative analysis of the functional properties of human and mouse ferroportin.

Cellular iron efflux Ferroportin disease Iron homeostasis Xenopus laevis oocyte

Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
20 Mar 2023
Historique:
pmc-release: 01 05 2024
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: aheadofprint

Résumé

Ferroportin (Fpn)-expressed at the plasma membrane of macrophages, enterocytes, and hepatocytes-mediates the transfer of cellular iron into the blood plasma. Under the control of the iron-regulatory hormone hepcidin, Fpn serves a critical role in systemic iron homeostasis. Whereas we have previously characterized human Fpn, a great deal of research in iron homeostasis and disorders utilizes mouse models. By way of example, the flatiron mouse, a model of classical ferroportin disease, bears the mutation H32R in Fpn and is characterized by systemic iron deficiency and macrophage iron retention. The flatiron mouse also appears to exhibit a manganese phenotype, raising the possibility that mouse Fpn serves a role in manganese metabolism. At odds with this observation, we have found that human Fpn does not transport manganese, so we considered the possibility that a species difference could explain this discrepancy. We tested the hypothesis that mouse but not human Fpn can transport manganese and performed a comparative analysis of mouse and human Fpn. We examined the functional properties of human Fpn, mouse Fpn, and mutant mouse Fpn by using radiotracer assays in RNA-injected

Identifiants

pubmed: 36939203
doi: 10.1152/ajpcell.00063.2023
pmc: PMC10191125
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ID : DK107309
Organisme : UC | College of Medicine, University of Cincinnati (University of Cincinnati College of Medicine)
Organisme : HHS | NIH | NHLBI | NHLBI Division of Intramural Research (DIR)
ID : HL115473
Organisme : U.S. Department of Energy (DOE)

Références

Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8955-60
pubmed: 15956209
Blood Adv. 2020 Oct 13;4(19):4758-4768
pubmed: 33007076
Blood. 2007 May 15;109(10):4174-80
pubmed: 17289807
Neuron. 1995 Sep;15(3):721-8
pubmed: 7546750
J Biol Chem. 2006 Apr 21;281(16):11161-6
pubmed: 16495228
Am J Physiol Cell Physiol. 2014 Mar 1;306(5):C450-9
pubmed: 24304836
Acta Haematol. 2009;122(2-3):140-5
pubmed: 19907151
Pflugers Arch. 2006 Jan;451(4):544-58
pubmed: 16091957
FASEB J. 2015 Jul;29(7):2726-33
pubmed: 25782988
Nature. 1995 Oct 5;377(6548):438-41
pubmed: 7566122
J Neurosci. 1998 May 1;18(9):3117-23
pubmed: 9547220
Nat Commun. 2018 Aug 6;9(1):3075
pubmed: 30082682
Science. 2004 Dec 17;306(5704):2090-3
pubmed: 15514116
Cell Metab. 2005 Mar;1(3):191-200
pubmed: 16054062
Physiol Rev. 2013 Oct;93(4):1721-41
pubmed: 24137020
Nature. 2020 Oct;586(7831):807-811
pubmed: 32814342
Haematologica. 2006 Jun;91(6):727-32
pubmed: 16769573
Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G1-6
pubmed: 16354771
Biophys J. 1994 Mar;66(3 Pt 1):912-22
pubmed: 8011923
Metallomics. 2019 May 22;11(5):959-967
pubmed: 30888356
Blood. 2018 Feb 22;131(8):899-910
pubmed: 29237594
J Comput Chem. 2013 Apr 30;34(11):974-85
pubmed: 23288787
Cell Metab. 2015 Nov 3;22(5):777-87
pubmed: 26437604
FEBS Open Bio. 2021 Jan;11(1):26-34
pubmed: 33190422
Nat Commun. 2015 Oct 13;6:8545
pubmed: 26461048
Curr Top Membr. 2012;69:113-36
pubmed: 23046649
Annu Rev Biophys. 2011;40:243-66
pubmed: 21351879
J Membr Biol. 2011 Oct;243(1-3):35-46
pubmed: 21877177
Blood. 2005 May 15;105(10):4096-102
pubmed: 15692071
Bioinformatics. 2012 Feb 1;28(3):331-41
pubmed: 22130595
Nature. 1995 Jun 15;375(6532):599-603
pubmed: 7791878
Biometals. 2016 Feb;29(1):147-55
pubmed: 26693922
Nat Commun. 2020 Nov 10;11(1):5686
pubmed: 33173040

Auteurs

Corbin R Azucenas (CR)

Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, Ohio, United States.
Medicine Sciences Program, University of Cincinnati, Cincinnati, Ohio, United States.
Systems Biology & Physiology Program, University of Cincinnati, Cincinnati, Ohio, United States.

T Alex Ruwe (TA)

Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, Ohio, United States.
Systems Biology & Physiology Program, University of Cincinnati, Cincinnati, Ohio, United States.

John P Bonamer (JP)

Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, Ohio, United States.

Bo Qiao (B)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States.

Tomas Ganz (T)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States.
Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Mika Jormakka (M)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Elizabeta Nemeth (E)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States.

Bryan Mackenzie (B)

Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, Ohio, United States.
Medicine Sciences Program, University of Cincinnati, Cincinnati, Ohio, United States.
Systems Biology & Physiology Program, University of Cincinnati, Cincinnati, Ohio, United States.

Classifications MeSH